BioIVT, a provider of biospecimens and related services, has acquired Ascendance Biotechnology, Inc. Ascendance was formed as a multinational cell-based assay company in November 2015 through the merger of Hepregen Corporation and the ESI BIO products division of BioTime Inc. As a result of the acquisition, BioIVT has added Hepregen’s HepatoPac, HepatoMune and HepatoStem liver cell and stem cell product lines to its drug safety testing and toxicology portfolios.
Hepregen’s products employ a patented cell micropatterning technology in which different cell types are plated on industry-standard micro-well plates in proprietary patterns. The plates provide in-vitro cellular co-cultures that have a longer life and improved function. The HepatoPac products feature primary hepatocytes and fibroblasts that have been micro-patterned to create hepatocyte islands surrounded by supportive stromal cells. This approach closely mimics the function of a human liver and allows the hepatocytes to maintain normal metabolic activity for several weeks.
With HepatoMune, the micro-patterned primary hepatocytes and fibroblasts are supplemented with primary Kupffer cells, creating highly functional human liver tissue that models inflammation-mediated hepatotoxicity. HepatoMune tri-cultures remain viable for at least ten days, retaining both liver cell and Kupffer cell functionality, and can be used for predicting clinical outcomes. HepatoStem applies the same micro-patterning technology to stem cells.
For further information about BioIVT visit www.bioivt.com
Latest from Tom Mulligan
- Concept Life Sciences forms Scientific Advisory Board
- Sangamo finalises TxCell acquisition
- Polyplus-transfection introduces new nanoparticle DNA transfection reagent
- The 6th SGS Biopharma Day Seminar: a new early-phase clinical trials paradigm
- Blacktrace expands its presence in Japan with new office in Kanagawa
- MaSTherCell doubles production capacity
- Absolute Antibody expands production facilities
- Optibrium and University of Nottingham collaborate on innovative teaching programme
- Diamond Pharma Services wins both Futures and Support categories at TOPRA Awards
- Droplet microfluidics offers new approach for studying plant cell biomechanics